~~<i id='F7D08CB14B'><strike id='F7D08CB14B'><tt id='F7D08CB14B'><pre id='F7D08CB14B'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-09-28 04:19:27 Page View：3

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Radiology is caught between AI's potential and concern for patients
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

RubyWallauforSTATAbbViewillpay$10billionforthebiotechfirmImmunogen,thecompanysaidThursday,acquiringa

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

STEFANIREYNOLDS/AFPviaGettyImagesUnderstandhowscience,healthpolicy,andmedicineshapetheworldeveryday.